CSIMarket
 


Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's Net Income Growth by Quarter and Year

Pfizer Inc's Net Income results by quarter and year




PFE Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -3,360.00 5,003.00 3,391.00 605.00
III Quarter September -2,376.00 8,623.00 8,159.00 2,202.00
II Quarter June 2,338.00 9,911.00 5,589.00 3,434.00
I Quarter March 5,556.00 7,870.00 4,886.00 3,410.00
FY   2,158.00 31,407.00 22,025.00 9,651.00



PFE Net Income fourth quarter 2023 Y/Y Growth Comment
Pfizer Inc in the fourth quarter 2023 recorded net loss of $ -3,360.00 millions.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Net Income growth. While Pfizer Inc' s Net Income no change of % ranks overall at the positon no. 438 in the fourth quarter 2023.




PFE Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 47.54 % 460.5 % -
III Quarter September - 5.69 % 270.53 % -71.34 %
II Quarter June -76.41 % 77.33 % 62.75 % -32.08 %
I Quarter March -29.4 % 61.07 % 43.28 % -12.32 %
FY   -93.13 % 42.6 % 128.21 % -40.8 %

Financial Statements
Pfizer Inc's fourth quarter 2023 Net Income $ -3,360.00 millions PFE's Income Statement
Pfizer Inc's fourth quarter 2022 Net Income $ 5,003.00 millions Quarterly PFE's Income Statement
New: More PFE's historic Net Income Growth >>


PFE Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -41.98 % -58.44 % -72.52 %
III Quarter September - -13 % 45.98 % -35.88 %
II Quarter June -57.92 % 25.93 % 14.39 % 0.7 %
I Quarter March 11.05 % 132.08 % 707.6 % -
FY (Year on Year)   -93.13 % 42.6 % 128.21 % -40.8 %




Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #36
Overall #438

Net Income Y/Y Growth Statistics
High Average Low
274.98 % 21.11 % -93.13 %
(Jul 01 2018)   (Dec 31 2023)
Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #36
Overall #438
Net Income Y/Y Growth Statistics
High Average Low
274.98 % 21.11 % -93.13 %
(Jul 01 2018)   (Dec 31 2023)

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Pfizer Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PFE's IV. Quarter Q/Q Net Income Comment
Current accomplishment of -3,360.00 millions by Pfizer Inc appear even more unfavourable considering the net loss -2,376.00 millions a quarter before.

Within Major Pharmaceutical Preparations industry Pfizer Inc achieved highest sequential Net Income growth. While Pfizer Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PFE's IV. Quarter Q/Q Net Income Comment
Current accomplishment of -3,360.00 millions by Pfizer Inc come out even less good considering the -2,376.00 millions net loss in the previous quarter.

Within Major Pharmaceutical Preparations industry Pfizer Inc achieved highest sequential Net Income growth. While Pfizer Inc's Net Income growth quarter on quarter, overall rank is .


Pfizer Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Oct 01 2023)
12 Months Ending
(Jul 02 2023)
12 Months Ending
(Apr 02 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Income 12 Months Ending $ 2,158.00 $ 10,521.00 $ 21,520.00 $ 29,093.00 $ 31,407.00
Y / Y Net Income Growth (TTM) -93.13 % -64.69 % -26.63 % 16.33 % 42.6 %
Year on Year Net Income Growth Overall Ranking # 188 # 247 # 396 # 213 # 271
Seqeuential Net Income Change (TTM) -79.49 % -51.11 % -26.03 % -7.37 % 5.41 %
Seq. Net Income Growth (TTM) Overall Ranking # 438 # 702 # 1175 # 1093 # 519




Cumulative Net Income growth Comment
Pfizer Inc's cumulative 12 months Net Income continue to drop, but on the faster rate at -93.13% year on year, at Dec 31 2023 compare to the -64.69% decrease at Oct 01 2023. If the Pfizer Inc's fiscal year would end at Dec 31 2023, annual Net Income would be $2,158 millions.

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 188, from total ranking in previous quarter at 247.

Net Income TTM Q/Q Growth Statistics
High Average Low
274.98 %
21.11 %
-93.13 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 15
Overall # 188

Net Income TTM Y/Y Growth Statistics
High Average Low
274.98 %
21.11 %
-93.13 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 36
S&P 500 # 438
Cumulative Net Income growth Comment
Pfizer Inc's cumulative 12 months Net Income continue to drop, but on the faster rate at -93.13% year on year, at Dec 31 2023 compare to the -64.69% decrease at Oct 01 2023. If the Pfizer Inc's fiscal year would end at Dec 31 2023, annual Net Income would be $2,158 millions.

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 188, from total ranking in previous quarter at 247.

Net Income TTM Q/Q Growth Statistics
High Average Low
274.98 %
21.11 %
-93.13 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 15
Overall # 188

Net Income TTM Y/Y Growth Statistics
High Average Low
274.98 %
21.11 %
-93.13 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 36
S&P 500 # 438




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
PFE's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for PFE's Competitors
Net Income Growth for Pfizer Inc's Suppliers
Net Income Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2023
Charles River Laboratories International inc -0.08%$ -0.081 millions
Sanuwave Health Inc -0.23%$ -0.232 millions
Regeneron Pharmaceuticals Inc -3.13%$ -3.133 millions
Haemonetics Corporation-5.17%$ -5.169 millions
Resmed Inc -7.16%$ -7.165 millions
Edwards Lifesciences Corporation-7.20%$ -7.204 millions
Star Equity Holdings Inc -9.48%$ -9.481 millions
Bristol myers Squibb Company-12.99%$ -12.988 millions
Gilead Sciences Inc -13.23%$ -13.227 millions
Utah Medical Products Inc-13.50%$ -13.499 millions
Alpha Tau Medical Ltd -13.64%$ -13.640 millions
Masimo Corp-17.13%$ -17.125 millions
Merit Medical Systems Inc-17.28%$ -17.281 millions
Fresenius Medical Care Ag-18.10%$ -18.099 millions
Qiagen N v -19.35%$ -19.354 millions
Mettler toledo International Inc -30.49%$ -30.485 millions
Avantor Inc -30.49%$ -30.487 millions
Sanofi-35.93%$ -35.926 millions
Icu Medical Inc-38.15%$ -38.151 millions
Amedisys Inc -39.71%$ -39.707 millions
Avanos Medical Inc -40.34%$ -40.341 millions
Embecta Corp -42.90%$ -42.898 millions
Pro dex Inc -43.12%$ -43.117 millions
Becton Dickinson And Company-44.79%$ -44.794 millions
Bio techne Corp-45.08%$ -45.075 millions
Harmony Biosciences Holdings inc -45.15%$ -45.150 millions
Exagen Inc -45.72%$ -45.721 millions
Amgen Inc -52.54%$ -52.537 millions
Biogen Inc -54.70%$ -54.704 millions
Taro Pharmaceutical Industries Ltd-56.33%$ -56.330 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com